P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL

Detalles Bibliográficos
Autores principales: Dimopoulos, MA, Oriol, A, Nahi, H, San-Miguel, J, Bahlis, NJ, Usmani, SZ, Rabin, N, Orlowski, RZ, Suzuki, K, Plesner, T, Yoon, SS, Ben Yehuda, D, Richardson, PG, Goldschmidt, H, Reece, D, Ahmadi, T, Qin, X, Garvin Mayo, W, Gai, X, Carey, J, Carson, R, Moreau, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009798/
http://dx.doi.org/10.1097/01.HS9.0000829592.26407.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009798/
http://dx.doi.org/10.1097/01.HS9.0000829592.26407.09

Ejemplares similares